Canadian Journal of Infectious Diseases and Medical Microbiology / 2024 / Article / Tab 3 / Research Article
Insight into the Burden of Antimicrobial Resistance among Bacterial Pathogens Isolated from Patients Admitted in ICUs of a Tertiary Care Hospital in India Table 3 Antimicrobial susceptibility pattern of predominant Gram-positive cocci.
Antibiotic name Staphylococcus aureus Enterococcus spR (%)I (%)S (%)R (%)I (%)S (%)Ampicillin — — — 74.51 0.00 25.49 Penicillin G 96.34 0.00 3.66 — — — Amoxicillin/clavulanic acid — — — 71.43 2.38 26.19 Gentamicin-high level — — — 65.57 0.00 34.43 Gentamicin 21.69 9.93 63.38 — — — Ciprofloxacin 58.30 12.11 29.60 79.63 7.41 12.96 Norfloxacin — — — 93.75 0.00 6.25 Erythromycin 77.01 7.66 15.33 81.97 13.11 4.92 Nitrofurantoin — — — 42.86 9.52 47.62 Linezolid 0.00 0.00 100.00 0.00 0.00 100.00 Vancomycin 0.00 0.00 100.00 16.67 0.00 83.33 Teicoplanin 0.00 0.00 100.00 23.73 1.69 74.58 Chloramphenicol 18.08 2.26 79.66 14.29 0.00 85.71 Doxycycline 8.42 5.86 85.71 58.62 5.17 36.21 Minocycline 3.62 2.90 93.48 69.23 3.85 26.92 Tetracycline 19.59 5.86 74.55 74.58 5.17 19.98 Cefoxitin (MRSA) 82.78 0.00 17.22 — — —